Trials / Terminated
TerminatedNCT02308865
Early Palliative Care in Metastatic Lung Cancer in Northern France
Impact of Early Palliative Care on Quality of Life and Survival of Patients With Non-small-cell Metastatic Lung Cancer in Northern France
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer
Detailed description
144 patients will be included; 72 per arm. * "Standard" Control arm: patient supported by the onco-respiratory service. * Intervention arm: patients benefit from early palliative care in addition to standard onco-pneumologic care. The main criterion of judgment is the TOI score measured at 12 weeks. FACTL questionnaires, HADS and PHQ-9 will be filled out before randomization , at 12 weeks and 21 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | multi disciplinary palliative care monthly consultations | multi disciplinary palliative care consultations with a doctor, a nurse, a psychologist and posibility of a physical therapist and a worship person.The primary consultation within 3 weeks inclusion and then every month at the same time that consultations onco-respiratory |
Timeline
- Start date
- 2014-10-17
- Primary completion
- 2018-02-23
- Completion
- 2018-02-23
- First posted
- 2014-12-04
- Last updated
- 2019-07-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02308865. Inclusion in this directory is not an endorsement.